Why the study?
Although polygenic risk scores are associated with coronary artery disease, their clinical potential for risk stratification at the single-patient level has not been established.
Does adding a polygenic risk score to clinical risk factors improve risk stratification for obstructive CAD in patients with stable chest pain?
Does adding a polygenic risk score to clinical risk factors improve risk stratification for obstructive CAD in patients with stable chest pain?
Adding a polygenic risk score to standard clinical risk factors improves risk stratification for obstructive CAD, potentially down-classifying risk in nearly a quarter of intermediate-risk patients.
May support refined CAD risk estimates in stable chest pain; leaves open outcome impact and requires prospective validation.
BACKGROUND: Polygenic risk scores (PRSs) are associated with coronary artery disease (CAD), but the clinical potential of using PRSs at the single-patient level for risk stratification has yet to be established. We investigated whether adding a PRS to clinical risk factors (CRFs) improves risk stratification in patients referred to coronary computed tomography angiography on a suspicion of obstructive CAD. METHODS: In this prespecified diagnostic substudy of the Dan-NICAD trial (Danish study of Non-Invasive testing in Coronary Artery Disease), we included 1617 consecutive patients with stable chest symptoms and no history of CAD referred for coronary computed tomography angiography. CRFs used for risk stratification were age, sex, symptoms, prior or active smoking, antihypertensive treatment, lipid-lowering treatment, and diabetes. In addition, patients were genotyped, and their PRSs were calculated. All patients underwent coronary computed tomography angiography. Patients with a suspected ≥50% stenosis also underwent invasive coronary angiography with fractional flow reserve. A combined end point of obstructive CAD was defined as a visual invasive coronary angiography stenosis >90%, fractional flow reserve <0.80, or a quantitative coronary analysis stenosis >50% if fractional flow reserve measurements were not feasible. RESULTS: ) was obtained, with a down-classification of risk in 24% of patients (211 of 862) in whom the pretest probability was 5% to 15% based on CRFs alone. CONCLUSIONS: Adding a PRS improved risk stratification of obstructive CAD beyond CRFs, suggesting a modest clinical potential of using PRSs to guide diagnostic testing in the contemporary clinical setting. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02264717.
No takes yet. Share an insight, caveat, or question.
Christiansen et al. (2021) studied this question.